HYBRID EVENT: You can participate in person at Paris, France or Virtually from your home or work.
EPN 2020

Steven M Donn

Steven M Donn, Speaker at Neonatal Conferences
University of Michigan, United States
Title : Pharmacologic management of bronchopulmonary dysplasia: Equipoise in the era of evidence


Bronchopulmonary dysplasia (BPD) is the leading cause of longterm respiratory disability among prematurely born infants and is a significant contributor to life-long neurodevelopmental problems. Affected infants are often exposed to a myriad of pharmacologic agents. In the neonatal intensive care unit. Many of these drugs are off label and have limited efficacy and significant toxicity. They include diuretics, bronchodilators, and agents to treat presumed gastro-esophageal reflux. This presentation will summarize the pulmonary injury sequence and the epidemiology of BPD. Various pharmacologic agents will be reviewed and evidence will be presented to balance their efficacy and safety. The presentation will conclude with a glimpse into evolving treatments


Steven M. Donn, MD, FAAP received his M.D. degree from Tulane University. He completed a Pediatrics residency at the University of Vermont and a fellowship in Neonatal-Perinatal Medicine at the University of Michigan. He has been on the faculty of the University of Michigan Medical School since 1980 and is presently a Professor Emeritus. He has published more than 200 medical articles, 250 book chapters, and has written or edited 35 books and specialty journals. He is a member of numerous professional organizations, including the AAP, SPR, APS, and ESPR